| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. | Other*, 10%+ Owner | Common Stock, $0.001 par value | 3,490,921 | $87,327,483 | $25.02 | 01 Sep 2023 | Indirect |
| Venus Concept Inc. | Other*, 10%+ Owner | Senior Convertible Preferred Stock | 1,575,810 | $6,271,724 | $3.98 | 20 Oct 2023 | I |
| Venus Concept Inc. | Other*, 10%+ Owner | Secured Subordinated Convertible Notes | $2,000,000 | 18 Jan 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERO | Venus Concept Inc. | 18 Jan 2024 | 1 | +$2,000,000 | 4 | Other*, 10%+ Owner | 19 Jan 2024, 16:05 |
| VERO | Venus Concept Inc. | 20 Oct 2023 | 1 | +$2,000,002 | 4 | Other*, 10%+ Owner | 20 Oct 2023, 16:10 |
| VERO | Venus Concept Inc. | 08 Sep 2023 | 1 | +$1,000,001 | 4 | Other*, 10%+ Owner | 12 Sep 2023, 16:28 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 01 Sep 2023 | 1 | -$197,982 | 4/A | Other*, 10%+ Owner | 06 Sep 2023, 19:10 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 30 Aug 2023 | 4 | -$1,470,208 | 4 | Other*, 10%+ Owner | 01 Sep 2023, 16:51 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 28 Aug 2023 | 3 | -$1,656,878 | 4 | Other*, 10%+ Owner | 30 Aug 2023, 17:46 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 24 Aug 2023 | 4 | -$2,487,482 | 4/A | Other*, 10%+ Owner | 30 Aug 2023, 17:32 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 22 Aug 2023 | 2 | -$2,264,748 | 4 | Other*, 10%+ Owner | 24 Aug 2023, 17:30 |
| VERO | Venus Concept Inc. | 12 Jul 2023 | 1 | $0 | 4 | Other*, 10%+ Owner | 13 Jul 2023, 10:53 |
| VERO | Venus Concept Inc. | 15 May 2023 | 1 | +$2,000,001 | 4 | Other*, 10%+ Owner | 17 May 2023, 11:52 |
| VERO | Venus Concept Inc. | 18 Nov 2022 | 2 | +$3,000,000 | 4/A | 10%+ Owner | 22 Nov 2022, 19:10 |
| VERO | Venus Concept Inc. | 15 Dec 2021 | 2 | +$4,900,000 | 4 | 10%+ Owner | 17 Dec 2021, 20:45 |